Published in Women's Health Weekly, July 17th, 2003
However, one prestratified subset of patients in the treatment group, women on hormonal treatment following chemotherapy, appeared to show a favorable trend to improvement in survival. Further analysis of this subset of patients is underway, as is additional analyses of the complete trial data.
Following this further analysis of the subset data, the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.